Skip to main content
Livermore
Livermore
ZHEN

Morgan Stanley

SEC CIK
0000895421
Latest filing
Aug 13, 2026

AVDL holding history

Avadel Pharmaceuticals PLC in every 13F filed by Morgan Stanley, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AVDL overviewAll 13F holders of AVDLFull Q2 2026 holdings

Shares (Q1 2026)
0
Sold out in Q1 2026
Value
$0
% of portfolio
0.0%
Quarters held
20
Since Q1 2021
Holdings of AVDL by Morgan Stanley, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20260$00.0%−529,074−100.0%Sold outHolders
Q4 2025529,074$11.4M<0.1%−1,729,609−76.6%ReducedHolders
Q3 20252,258,683$34.5M<0.1%+1,066,077+89.4%AddedHolders
Q2 20251,192,606$10.6M<0.1%+157,992+15.3%AddedHolders
Q1 20251,034,614$8.10M<0.1%−174,782−14.5%ReducedHolders
Q4 20241,209,396$12.7M<0.1%+260,992+27.5%AddedHolders
Q3 2024948,404$12.4M<0.1%+115,092+13.8%AddedHolders
Q2 2024833,312$11.7M<0.1%+167,901+25.2%AddedHolders
Q1 2024665,411$11.2M<0.1%−326,586−32.9%ReducedHolders
Q4 2023991,997$14.0M<0.1%+554,941+127.0%AddedHolders
Q3 2023437,056$4.50M<0.1%−24,038−5.2%ReducedHolders
Q2 2023461,094$7.60M<0.1%+115,383+33.4%AddedHolders
Q1 2023345,711$3.17M<0.1%−1,609−0.5%ReducedHolders
Q4 2022347,320$2.49M<0.1%+468+0.1%AddedHolders
Q3 2022346,852$1.74M<0.1%+30,491+9.6%AddedHolders
Q2 2022316,361$772.0K<0.1%−26,648−7.8%ReducedHolders
Q1 2022343,009$2.34M<0.1%−114,255−25.0%ReducedHolders
Q4 2021457,264$3.69M<0.1%+33,044+7.8%AddedHolders
Q3 2021424,220$4.16M<0.1%+47,955+12.7%AddedHolders
Q2 2021376,265$2.53M<0.1%+152,186+67.9%AddedHolders
Q1 2021224,079$2.03M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.